Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)
China flag China · Delayed Price · Currency is CNY
18.08
-0.20 (-1.09%)
Aug 11, 2026, 3:04 PM CST

SHE:000623 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
2,2272,3352,6113,4492,8682,304
Revenue Growth
-6.12%-10.55%-24.31%20.25%24.50%2.31%
Gross Profit
1,0201,0641,0081,6811,4511,193
Operating Income
-148.15-165.14-160.4134.53129.915.87
Net Income
2,7442,3951,5511,4601,7811,781
Earnings Per Share
2.342.041.321.231.471.51
EPS Growth
44.72%54.91%7.39%-16.35%-2.93%5.70%

Revenue by Segment

Fiscal YearFY 2025
Period EndingDec '25
Other Segment
140.82
Medicine
1,798
Group Investment Division
1.65
Food
199.7
Offset of Business Segment
-188.42
Chain drugstore wholesale and retail
383.29
Total
2,335

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
2,8972,9632,6753,3783,8664,635
Total Debt
2,2492,2392,2893,0322,9902,616
Net Cash (Debt)
647.98724385.96346.02875.842,020
Net Cash Growth
137.88%87.58%11.54%-60.49%-56.63%-0.57%
Net Cash Per Share
0.550.620.330.270.671.60

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
227.01272.2659.4868.06423.86324.85
Capital Expenditures
-112.55-128.45-273.98-419.52-270.97-313.3
Free Cash Flow
114.46143.81-214.5-351.46152.8911.54
Free Cash Flow Growth
----1224.31%-92.92%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
45.81%45.58%38.62%48.74%50.59%51.76%
Operating Margin
-6.65%-7.07%-6.14%3.90%4.53%0.26%
Pretax Margin
123.82%103.66%58.28%43.49%60.00%76.69%
Profit Margin
123.25%102.57%59.43%42.33%62.09%77.29%
FCF Margin
5.14%6.16%-8.22%-10.19%5.33%0.50%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
0.5000.5000.5000.6000.3000.300
Dividend Per Share Growth
0%0%-16.67%100.00%0%50.00%
Dividend Yield
2.74%2.60%3.03%4.38%2.26%1.87%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
7.729.5613.3111.719.5611.81
Forward PE
-7.008.058.0224.0324.03
P/FCF Ratio
185.19159.22--111.321821.95
PS Ratio
9.529.817.914.965.939.13